통원치료센터 단기항암요법 환자의 부작용 양상 및 약사의 중재활동 효과

키워드

참고문헌 (26)

1. Lau P.M, "ten most common adverse drug reactions (ADRs) in oncology patients: do they matter to you?", Support Care Cancer, 12(9), pp.626~633 (2004)
2. 김윤정, "진행성 위암에서 항암 화학 치료로 완전 반응을 보인 환자들의 복합 항암 화학요법의 독성과 효능의 비교 분석", 대한소화기학회지, 58(6), pp.311~317 (2011), 대한소화기학회
3. Im S.A, "Phase II trial of preoperative paclitaxel, gemcitabine, and trastuzumab combination therapy in HER2 positive stage II", III breast cancer; The Korean Cancer Study Group BR 07- 01, 2011, ~
4. Watanabe K, "Safety and tolerance of docetaxel (especially 75 mg", m2) with cyclophosphamide (TC therapy) as adjuvant chemotherapy for Japanese patients with operable breast cancer, 2010, pp.37(7), 1265~1269
5. Jang J.S, "Gemcitabine and oxaliplatin in patients with unresectable biliary cancer including gall bladder cancer-a Korean Cancer Study Group phase II trial", Cancer Chemother Pharmacol, 65(4), pp.641~647 (2010)
6. Kawazoe H, "Nephrotoxicity induced by repeated cycles of oxaliplatin in a Japanese colorectal cancer patient with moderate renal impairment", Gan To Kagaku Ryoho, 37(6), pp.1153~1157 (2010)
7. Gawert L, "The importance of patient perspective in drug surveillance systems", Z Rheumatol, 69(9), pp.795~802 (2010)
8. van Grootheest A.C, "The role of hospital and community pharmacists in pharmacovigilance", Res Social Adm Pharm, 1(1), pp.126~133 (2005)
9. 손기호, "실무중심의 병원약학, 초판", pp.311~325 (2009), 군자출판사
10. 식품의약품 안전청 약물감시사업단, "약물감시용어표준화에 관한 연구", WHO-ART 092 한글 개정판, ~ (2008)
11. 홍경섭, "약물이상반응의 인과성 평가를 위한 한국형 알고리즘의 개발", 임상약리학회지, 10(2), pp.129~142 (2002), 대한임상약리학회
12. Basch E, "Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study", Lancet Oncol, 7(11), pp.903~909 (2006)
13. Oken M.M, "Toxicity and Response Criteria of the Eastern Cooperative Oncology Group", Am J Clin Oncol, 5, pp.649~655 (1982)
14. 이수정, "Definitive Chemoradiotherapy with Capecitabine and Cisplatin in Patients with Esophageal Cancer: A Pilot Study", Journal of Korean Medical Science, 24(1), pp.120~125 (2009), 대한의학회
15. Chua D.T, "Phase II trial of capecitabine plus cisplatin as first-line therapy in patients with metastatic nasopharyngeal cancer", Head Neck (2011)
16. Won Y.W, "A phase II study of combination chemotherapy with capecitabine and cisplatin in patients with metastatic or recurrent squamous cell carcinoma of the head and neck", ANNALS OF ONCOLOGY, 22(2), pp.417~423 (2011), OXFORD UNIV PRESS
17. Lee J.O, "Combination chemotherapy with capecitabine and cisplatin for patients with metastatic hepatocellular carcinoma", Ann Oncol, 20(8), pp.1402~1407 (2009)
18. 조현일, "고위험 자궁경부암의 수술 후 보조요법으로서 Paclitaxel과Carboplatin 동시 항암화학방사선요법의 효능과 안전성", Obstetrics & Gynecology Science, 47(5), pp.917~923 (2004), 대한산부인과학회
19. 양성우, "Paclitaxel과 Carboplatin 항암 화학 요법 후에 발생한 위막 대장염 1예", 대한소화기학회지, 54(5), pp.328~332 (2009), 대한소화기학회
20. Junshik Hong, "Additional rituximab-CHOP (R-CHOP) versus involved-field radiotherapy after a brief course of R-CHOP in limited, non-bulky diffuse large B-cell lymphoma: a retrospective analysis", Blood Research, 45(4), pp.253~259 (2010), 대한혈액학회
21. 임규형, "Severe Pulmonary Adverse Effects in Lymphoma Patients Treated with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) Regimen Plus Rituximab", The Korean Journal of Internal Medicine, 25(1), pp.86~92 (2010), 대한내과학회
22. Marino D, "Neurological syndrome after RCHOP chemotherapy for a non-Hodgkin lymphoma: what is the diagnosis?", Int J Hematol, 94(5), pp.461~462 (2011)
23. Preveling-Oberhag, "Antiviral therapy of chronic hepatitis C in patients with advanced liver disease and after liver transplantation", Med Microbiol Immunol, 199(1), pp.1~10 (2010)
24. Desai C.K, "An evaluation of knowledge, attitude, and practice of adverse drug reaction reporting among prescribers at a tertiary care hospital", Perspect Clin Res, 2(4), pp.129~136 (2011)
25. 이용수, "건설현장의 재해율 저감을 위한 개선방안 연구", 한국경영공학회지, 16(3), pp.99~113 (2011), 한국경영공학회
26. Cioffi P, "The impact of a pharmacist as a member of healthcare team on facilitating evidenced- based prescribing of innovative drugs in an Italian oncology department", J Oncol Pharm Pract (2011)

관련 논문AI추천